A proteína de armazón codificada neste xene é o principal compoñente das caveolas da membrana plasmática que se encontran na maioría dos tipos celulares. A proteína enlaza subunidades de integrinas á tirosina quinase FYN, un paso inicial no acoplamento de integrina á vía Ras-ERK e na promoción da progresión do ciclo celular. O xene é un supresor de tumores candidato e un regulador negativo da fervenza da Ras-p42/44 MAP quinase. Os xenes CAV1 e CAV2 están localizados un a carón do outro no cromosoma 7 e expresan proteínas colocalizadas que forman un complexo heterooligomérico estable. Utilizando codóns de iniciación alternativos no mesmo marco de lectura, as dúas isoformas que existen da caveolina 1 (alfa e beta) son codificadas por un só transcrito deste xene.[2]
↑Fra AM, Mastroianni N, Mancini M, Pasqualetto E, Sitia R (March 1999). "Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors". Genomics56 (3): 355–6. PMID10087206. doi:10.1006/geno.1998.5723.
↑Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP (June 1995). "Evidence for a regulated interaction between heterotrimeric G proteins and caveolin". The Journal of Biological Chemistry270 (26): 15693–701. PMID7797570. doi:10.1074/jbc.270.26.15693.
↑Li S, Song KS, Lisanti MP (January 1996). "Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes". The Journal of Biological Chemistry271 (1): 568–73. PMID8550621. doi:10.1074/jbc.271.1.568.
↑Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP (March 2001). "Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor". The Journal of Biological Chemistry276 (9): 6727–38. PMID11102446. doi:10.1074/jbc.M008340200.
↑García-Cardeña G, Fan R, Stern DF, Liu J, Sessa WC (November 1996). "Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1". The Journal of Biological Chemistry271 (44): 27237–40. PMID8910295. doi:10.1074/jbc.271.44.27237.
↑Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (April 2001). "Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation". The Journal of Biological Chemistry276 (16): 13442–51. PMID11278309. doi:10.1074/jbc.M006598200.
↑Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T (April 1998). "Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein". The Journal of Biological Chemistry273 (17): 10485–95. PMID9553108. doi:10.1074/jbc.273.17.10485.
↑Schubert AL, Schubert W, Spray DC, Lisanti MP (May 2002). "Connexin family members target to lipid raft domains and interact with caveolin-1". Biochemistry41 (18): 5754–64. PMID11980479. doi:10.1021/bi0121656.
↑Couet J, Sargiacomo M, Lisanti MP (November 1997). "Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities". The Journal of Biological Chemistry272 (48): 30429–38. PMID9374534. doi:10.1074/jbc.272.48.30429.
↑Yamaguchi T, Murata Y, Fujiyoshi Y, Doi T (April 2003). "Regulated interaction of endothelin B receptor with caveolin-1". European Journal of Biochemistry270 (8): 1816–27. PMID12694195. doi:10.1046/j.1432-1033.2003.03544.x.
↑ 14,014,1Yamamoto M, Toya Y, Jensen RA, Ishikawa Y (March 1999). "Caveolin is an inhibitor of platelet-derived growth factor receptor signaling". Experimental Cell Research247 (2): 380–8. PMID10066366. doi:10.1006/excr.1998.4379.
↑Liou JY, Deng WG, Gilroy DW, Shyue SK, Wu KK (September 2001). "Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts". The Journal of Biological Chemistry276 (37): 34975–82. PMID11432874. doi:10.1074/jbc.M105946200.
↑Feng X, Gaeta ML, Madge LA, Yang JH, Bradley JR, Pober JS (March 2001). "Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors". The Journal of Biological Chemistry276 (11): 8341–9. PMID11112773. doi:10.1074/jbc.M007116200.
↑Cao H, Courchesne WE, Mastick CC (March 2002). "A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase". The Journal of Biological Chemistry277 (11): 8771–4. PMID11805080. doi:10.1074/jbc.C100661200.
↑Breuza L, Corby S, Arsanto JP, Delgrossi MH, Scheiffele P, Le Bivic A (December 2002). "The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells". Journal of Cell Science115 (Pt 23): 4457–67. PMID12414992. doi:10.1242/jcs.00130.
↑Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP (November 1997). "Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo". The Journal of Biological Chemistry272 (46): 29337–46. PMID9361015. doi:10.1074/jbc.272.46.29337.
↑Czarny M, Fiucci G, Lavie Y, Banno Y, Nozawa Y, Liscovitch M (February 2000). "Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains". FEBS Letters467 (2–3): 326–32. PMID10675563. doi:10.1016/S0014-5793(00)01174-1.
↑Vargas L, Nore BF, Berglof A, Heinonen JE, Mattsson PT, Smith CI, Mohamed AJ (March 2002). "Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx". The Journal of Biological Chemistry277 (11): 9351–7. PMID11751885. doi:10.1074/jbc.M108537200.
↑Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP (March 1997). "Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins". The Journal of Biological Chemistry272 (10): 6525–33. PMID9045678. doi:10.1074/jbc.272.10.6525.
Razani B, Schlegel A, Liu J, Lisanti MP (August 2001). "Caveolin-1, a putative tumour suppressor gene". Biochemical Society Transactions29 (Pt 4): 494–9. PMID11498016. doi:10.1042/BST0290494.
Fujimoto T, Kogo H, Nakamura N, Ozeki S (March 2002). "[Microdomains and caveolin]". Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme47 (4 Suppl): 326–32. PMID11915322.
Shatz M, Liscovitch M (September 2004). "Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins?". Leukemia Research28 (9): 907–8. PMID15234566. doi:10.1016/j.leukres.2004.03.013.
Frank PG, Lisanti MP (January 2007). "Caveolin-1 and liver regeneration: role in proliferation and lipogenesis". Cell Cycle6 (2): 115–6. PMID17314510. doi:10.4161/cc.6.2.3722.